Ordinary Adjustment | Solactive Global Health Services & Technology Americas | Effective Date 16th October 2025
Solactive Global Health Services & Technology Americas:
In the ordinary adjustment, the following composition will be implemented effective open 16th October 2025:
ABBOTT LABORATORIES |
ABBVIE INC |
ADDUS HOMECARE CORP |
AMGEN INC |
AMNEAL PHARMACEUTICALS INC |
BIOGEN INC |
BOSTON SCIENTIFIC CORP |
BRISTOL-MYERS SQUIBB CO |
CIGNA GROUP |
CONCENTRA GROUP HOLDINGS PARENT ORD |
DAVITA INC |
EDWARDS LIFESCIENCES CORP |
ENCOMPASS HEALTH CORP |
ENSIGN GROUP INC |
GILEAD SCIENCES INC |
HCA HEALTHCARE INC |
HOLOGIC INC |
INCYTE CORP |
INNOVIVA INC |
INTEGER HOLDINGS CORP |
JOHNSON & JOHNSON |
LABCORP HOLDINGS INC |
MEDTRONIC PLC |
MERCK & CO. INC. |
NATIONAL HEALTHCARE CORP |
OPTION CARE HEALTH INC |
PFIZER INC |
PREMIER INC |
PRESTIGE CONSUMER HEALTHCARE INC |
QIAGEN NV |
QUEST DIAGNOSTICS INC |
REDE D OR SAO LUIZ SA |
RESMED INC |
ROYALTY PHARMA PLC- CL A |
SOLVENTUM CORP |
STERIS PLC |
STRYKER CORP |
TELEFLEX INC |
ZIMMER BIOMET HOLDINGS INC |
ZOETIS INC |